| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.92% | 58.17% | 60.75% | 55.44% | 58.79% | 64.48% | 65.73% | 60.23% | 60.65% | 69.21% | 65.86% | 63.11% |
| Operating Margin | 5.44% | -10.30% | -11.13% | -11.65% | -6.97% | -1.41% | -3.48% | -83.21% | -45.80% | -8.38% | -20.35% | -17.73% |
| EBITDA Margin | 9.34% | -6.69% | -7.65% | -9.42% | -4.56% | 2.49% | 1.38% | -74.08% | -35.62% | -0.34% | -12.11% | -15.04% |
| Net Margin | 3.71% | -14.03% | 0.72% | -14.64% | -8.77% | -13.17% | -12.71% | -97.09% | -63.44% | -21.66% | -3.66% | -29.74% |
| Current Ratio | 2.65 | 2.35 | 2.82 | 3.24 | 4.00 | 1.22 | 3.43 | 2.88 | 1.53 | 1.57 | 2.12 | 2.25 |
| Quick Ratio | 1.63 | 1.00 | 1.22 | 2.10 | 2.38 | 0.39 | 1.72 | 1.44 | 0.67 | 0.73 | 1.06 | 1.13 |
| Debt / Equity | 0.29 | 0.51 | 0.33 | 0.35 | 0.38 | 1.16 | -1.72 | -1.78 | -1.14 | -16.86 | 5.04 | -2.69 |
| ROE | 9.76% | -38.29% | 1.29% | -24.83% | -15.70% | -48.39% | 18.60% | 160.15% | 89.29% | 275.59% | -24.50% | 135.15% |
| ROA | 5.28% | -17.53% | 0.71% | -14.09% | -8.87% | -16.94% | -19.05% | -151.00% | -49.58% | -13.53% | -1.52% | -37.59% |
| Asset Turnover | 1.42 | 1.25 | 0.99 | 0.96 | 1.01 | 1.29 | 1.50 | 1.56 | 0.78 | 0.62 | 0.41 | 1.26 |
| Book Value / Share | 0.34 | 0.32 | 0.40 | 0.36 | 0.36 | 0.51 | -3.36 | -3.73 | -38.93 | -0.56 | 0.98 | -1.31 |
Xtant Medical Holdings Inc. is a leading company in the medical device sector, specializing in the development and distribution of regenerative medicine products and surgical implants. The core purpose of the company is to improve patient outcomes through innovative solutions in orthopedic and neurological surgery. Xtant Medical’s product offerings include biologics and other advanced materials designed to support the healing and repair of tissue, primarily within the spine and broader orthopedics market. Their products are integral in the treatment of complex injuries and conditions, playing a crucial role in both surgical intervention and recovery processes. Based in the healthcare industry, Xtant Medical Holdings Inc. serves hospitals, surgical centers, and clinics, providing essential tools for managing patient care. In the financial market, Xtant's products and innovations position the company as a critical provider within the medical technology landscape, underlining its market presence and influence in advancing medical treatments.